ArticleCancers2024

Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer

Collin A Sitler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.